Clinical Report: A Bibliometric Examination of TLS in Autoimmune Disorders

Overview

This bibliometric analysis identifies trends in research on tertiary lymphoid structures (TLSs) in autoimmune diseases. The study highlights the increasing interest in TLSs, particularly in relation to diseases such as rheumatoid arthritis and systemic lupus erythematosus.

Background

Tertiary lymphoid structures (TLSs) are critical components of the immune response in chronic inflammation and autoimmunity. This analysis provides insights into the evolving landscape of TLS research.

Data Highlights

Key Findings

• 479 publications on TLSs in autoimmune diseases were analyzed.
• Annual publication output showed an upward trend.
• The United States led in international collaboration on TLS research.
• Major diseases studied included rheumatoid arthritis, Sjögren’s syndrome, and systemic lupus erythematosus.
• Research has shifted from structural recognition of TLSs to functional interpretation and disease stratification.
• Recent advancements include studies on T follicular helper cells and single-cell omics approaches.

Clinical Implications

Understanding the functional aspects of TLSs could enhance disease stratification and treatment personalization.

Conclusion

The evolution of TLS research reflects a shift towards understanding their functional roles in autoimmune diseases.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Studies on allergic diseases and B cells in the past 20 years: a bibliometric analysis via CiteSpace and VOSviewer
2. Frontiers in Immunology, 2026 -- Tertiary lymphoid structures in breast cancer: formation, immune functions and clinical implications
3. Frontiers in Immunology, 2026 -- Research trends on autoimmune liver diseases and gut microbiota (1989–2025): a bibliometric and visualization analysis based on the web of science core collection database
4. Clinical Rheumatology, 2025 -- A bibliometric review of immunotherapy approaches for systemic lupus erythematosus: an evaluation of literature from 2014 to 2024
5. Signal Transduction and Targeted Therapy, 2024 -- Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
6. EULAR -- Recommendations Management
7. KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
8. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances | Signal Transduction and Targeted Therapy
9. Recommendations Management | EULAR
10. KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis